Why Is No One Talking About Dr. Reddy's Stock?

·4-min read
Why Is No One Talking About Dr. Reddy's Stock?

Dr. Reddy's Laboratories (NYSE: RDY) may be one of the best medical stocks you haven't heard of. The pharmaceutical company concentrates on generic and biosimilar medicines for cardiovascular disease, pain management, oncology, gastrointestinal ailments, dermatology, anti-infection treatments, and pediatrics. The company's stock is down slightly this year (1.42%), but up more than 35% over the past 12 months, and trends are working in the company's favor.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting